Department of Endocrinology, Paris-Sud University and Paris Saclay University, Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
Department of Endocrinology, Bordeaux University, Haut-Lévêque Hospital, Pessac, France.
Eur J Endocrinol. 2020 Apr;182(4):R29-R58. doi: 10.1530/EJE-19-0877.
Ectopic ACTH syndrome (EAS) is rare but is frequently a severe condition because of the intensity of the hypercortisolism that may be dissociated from the tumoral condition. EAS should often be considered as an endocrine emergency requiring an emergency response both in terms of diagnostic procedures and therapeutic interventions. Patient management is complex and necessitates dual skills, in the diagnosis and treatment of CS and in the specific management of neuroendocrine tumors (NET). Therefore, initial management should be performed ideally by experienced endocrinology teams in collaboration with specialized hormonal laboratory, modern imaging platforms and intensive care units. Diagnostic procedures vary according to the endocrine and tumoral contexts but should be reduced to a minimum in intense hypercortisolism. Preventive and curative treatments of cortisol-induced comorbidities, non-specific management of hypercortisolism and etiological treatments should be considered simultaneously. Therapeutic strategies vary according to (1.) the intensity of hypercortisolism, the general condition of the patient and associated comorbidities and (2.) the tumoral status, ranging from resectable ACTH secreting tumors to non-resectable metastatic endocrine tumors or occult tumors. The ideal treatment is complete excision of the ACTH-secreting tumor that can be performed rapidly or after preoperative preparation using cortisol-lowering drugs. When this is not possible, the therapeutic strategy should be discussed by a multidisciplinary experienced team in a personalized perspective and include variable combinations of pharmacological agents, bilateral adrenalectomy and non-specific tumoral interventions. Here we discuss the diagnosis and therapeutic strategies including the modern, currently available tools and emphasize on the operational effectiveness of care.
异位促肾上腺皮质激素(ACTH)综合征(EAS)较为罕见,但由于皮质醇过度分泌的强度可能与肿瘤状况分离,因此通常是一种严重的疾病。EAS 通常应被视为内分泌急症,无论是在诊断程序还是治疗干预方面都需要紧急应对。患者管理复杂,需要双重技能,即 CS 的诊断和治疗以及神经内分泌肿瘤(NET)的特定管理。因此,最初的管理应由经验丰富的内分泌学团队与专门的激素实验室、现代成像平台和重症监护病房合作进行。诊断程序根据内分泌和肿瘤情况而有所不同,但在强烈的皮质醇过度分泌时应尽量减少。应同时考虑预防和治疗皮质醇引起的合并症、非特异性皮质醇过度分泌的管理和病因治疗。治疗策略根据(1.)皮质醇过度分泌的强度、患者的一般状况和相关合并症以及(2.)肿瘤状况而有所不同,范围从可切除的 ACTH 分泌肿瘤到不可切除的转移性内分泌肿瘤或隐匿性肿瘤。理想的治疗方法是快速切除 ACTH 分泌肿瘤,或者在使用皮质醇降低药物进行术前准备后切除。当这不可能时,应通过多学科经验丰富的团队以个性化的角度讨论治疗策略,包括药物治疗、双侧肾上腺切除术和非特异性肿瘤干预的各种组合。在这里,我们讨论了诊断和治疗策略,包括现代、目前可用的工具,并强调了护理的操作有效性。